Compare CYRX & HCIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CYRX | HCIC |
|---|---|---|
| Founded | 1999 | N/A |
| Country | United States | United States |
| Employees | 1100 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 419.3M | 352.6M |
| IPO Year | 2008 | 2026 |
| Metric | CYRX | HCIC |
|---|---|---|
| Price | $14.77 | $9.93 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $13.31 | N/A |
| AVG Volume (30 Days) | ★ 816.2K | N/A |
| Earning Date | 05-04-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 156.22 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $176,177,000.00 | N/A |
| Revenue This Year | $11.06 | N/A |
| Revenue Next Year | $8.45 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.69 | N/A |
| 52 Week High | $16.73 | N/A |
| Indicator | CYRX | HCIC |
|---|---|---|
| Relative Strength Index (RSI) | 53.76 | N/A |
| Support Level | $14.29 | N/A |
| Resistance Level | $16.73 | N/A |
| Average True Range (ATR) | 0.64 | 0.00 |
| MACD | -0.24 | 0.00 |
| Stochastic Oscillator | 14.52 | 0.00 |
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.
Hennessy Capital Investment Corp VIII is a blank check company.